As of April 18, 2025, Revvity (RVTY) has a market cap of $11.03 billion USD. According to our data, Revvity is ranked No.1506 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 18, 2025 | $11.03 B |
-18.73%
|
Dec 31, 2024 | $13.58 B |
2.37%
|
Dec 29, 2023 | $13.26 B |
-21.87%
|
Dec 30, 2022 | $16.97 B |
-30.13%
|
Dec 31, 2021 | $24.29 B |
40.37%
|
Dec 31, 2020 | $17.30 B |
48.20%
|
Dec 31, 2019 | $11.68 B |
24.01%
|
Dec 31, 2018 | $9.42 B |
7.80%
|
Dec 29, 2017 | $8.73 B |
40.85%
|
Dec 30, 2016 | $6.20 B |
-2.12%
|
Dec 31, 2015 | $6.34 B |
23.21%
|
Dec 31, 2014 | $5.14 B |
6.75%
|
Dec 31, 2013 | $4.82 B |
30.95%
|
Dec 31, 2012 | $3.68 B |
60.44%
|
Dec 30, 2011 | $2.29 B |
-21.63%
|
Dec 31, 2010 | $2.93 B |
27.03%
|
Dec 31, 2009 | $2.30 B |
50.65%
|
Dec 31, 2008 | $1.53 B |
-45.93%
|
Dec 31, 2007 | $2.83 B |
18.33%
|
Dec 29, 2006 | $2.39 B |
-4.40%
|
Dec 30, 2005 | $2.50 B |
6.19%
|
Dec 31, 2004 | $2.35 B |
33.78%
|
Dec 31, 2003 | $1.76 B |
112.02%
|
Dec 31, 2002 | $0.83 B |
-75.72%
|
Dec 31, 2001 | $3.42 B |
-32.69%
|
Dec 29, 2000 | $5.08 B |
154.17%
|
Dec 31, 1999 | $2.00 B |
52.58%
|
Dec 31, 1998 | $1.31 B |
36.67%
|
Dec 31, 1997 | $0.96 B |
6.26%
|
Dec 31, 1996 | $0.90 B |
-14.62%
|
Dec 29, 1995 | $1.06 B |
79.40%
|
Dec 30, 1994 | $0.59 B |
-20.45%
|
Dec 31, 1993 | $0.74 B |
-3.93%
|
Dec 31, 1992 | $0.77 B |
-19.71%
|
Dec 31, 1991 | $0.96 B |
64.03%
|
Dec 31, 1990 | $0.58 B |
-6.85%
|
Dec 29, 1989 | $0.63 B |
20.82%
|
Dec 30, 1988 | $0.52 B |
-11.97%
|
Dec 31, 1987 | $0.59 B |
19.62%
|
Dec 31, 1986 | $0.49 B |
-25.27%
|
Dec 31, 1985 | $0.66 B |
22.97%
|
Dec 31, 1984 | $0.54 B |
-1.42%
|
Dec 30, 1983 | $0.54 B |
15.96%
|
Dec 31, 1982 | $0.47 B |
43.04%
|
Dec 31, 1981 | $0.33 B |
-9.46%
|
Dec 31, 1980 | $0.36 B |
78.52%
|
Dec 31, 1979 | $0.20 B |
68.53%
|
Dec 29, 1978 | $0.12 B |
63.38%
|
Dec 30, 1977 | $73.79 M |
4.41%
|
Dec 31, 1976 | $70.67 M |
20.35%
|
Dec 31, 1975 | $58.72 M |
13.00%
|
Dec 31, 1974 | $51.96 M |
-29.58%
|
Dec 31, 1973 | $73.79 M |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Eli Lilly
LLY
|
$754.27 B |
0.008 M
|
![]() USA
|
![]() Johnson & Johnson
JNJ
|
$379.48 B |
-0.003 M
|
![]() USA
|
![]() AbbVie
ABBV
|
$306.02 B |
0.008 M
|
![]() USA
|
![]() Novo Nordisk
NVO
|
$285.37 B |
89.978 B
|
![]() Denmark
|
![]() Novo Nordisk A/S
NOVO-B.CO
|
$285.54 B |
69.140 B
|
![]() Denmark
|
![]() Roche
ROG.SW
|
$251.12 B |
35.293 B
|
![]() Switzerland
|
![]() Novartis
NVS
|
$219.89 B |
0.932 B
|
![]() Switzerland
|
![]() AstraZeneca
AZN
|
$210.29 B |
0.735 B
|
![]() UK
|
![]() Merck
MRK
|
$196.28 B |
0.008 M
|
![]() USA
|
![]() Thermo Fisher Scientific
TMO
|
$161.38 B |
-0.001 M
|
![]() USA
|
![]() Amgen
AMGN
|
$149.09 B |
0.124 B
|
![]() USA
|
![]() Gilead Sciences
GILD
|
$130.32 B |
-0.001 M
|
![]() USA
|
![]() Vertex Pharmaceuticals
VRTX
|
$125.74 B |
-0.003 M
|
![]() USA
|
![]() Pfizer
PFE
|
$125.57 B |
0.001 M
|
![]() USA
|
![]() Sanofi
SNY
|
$124.64 B |
0.327 B
|
![]() France
|
![]() Bristol-Myers Squibb
BMY
|
$100.17 B |
-0.004 M
|
![]() USA
|
![]() Chugai Pharmaceutical
4519.T
|
$96.41 B |
14.389 B
|
![]() Japan
|
![]() CSL
CSL.AX
|
$73.92 B |
0.002 M
|
![]() Australia
|
![]() GlaxoSmithKline
GSK
|
$72.79 B |
-0.000 M
|
![]() UK
|
![]() Zoetis
ZTS
|
$66.32 B |
-0.000 M
|
![]() USA
|
Market Cap | = | RVTY Stock Price | * | RVTY Shares Outstanding |
= | $91.82 | * | 0.12 B | |
= | $11.03 B |